Contact
Please use this form to send email to PR contact of this press release:
ORYZON Announces FDA Orphan Drug Designation Granted to iadademstat for Treatment of Acute Myeloid Leukemia
TO:
Please use this form to send email to PR contact of this press release:
ORYZON Announces FDA Orphan Drug Designation Granted to iadademstat for Treatment of Acute Myeloid Leukemia
TO: